Donald Notman, Chief Financial Officer at OCULAR THERAPEUTIX, INC (OCUL), bought 12,500 shares at $6.29 ($79K) on 2018-08-14, disclosed to the SEC on 2018-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| OCUL | SELL | 2026-02-04 | $101K | — | Filing → |
| OCUL | SELL | 2025-09-04 | $13K | — | Filing → |
| OCUL | SELL | 2025-02-04 | $223K | — | Filing → |